Comparing two iron supplements for treating anemia in children
Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients With Iron Deficiency Anemia
This study tests which of two iron supplements works better for treating anemia in children.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 198 (estimated) |
| Ages | 6 Months to 5 Years |
| Sex | All |
| Sponsor | Khyber Teaching Hospital Academic / other |
| Locations | 1 site (Peshawar, KPK) |
| Trial ID | NCT06742528 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of two commonly used iron supplements, Ferrous Sulphate and Iron Polymaltose Complex, in treating iron deficiency anemia in pediatric patients. The research aims to evaluate their efficacy, bioavailability, side effects, and cost to determine which preparation is more beneficial for children in the local population. By analyzing these factors, the study seeks to provide clearer guidance for pediatricians in managing this prevalent condition. The trial will include children diagnosed with iron deficiency anemia while excluding those with certain blood disorders or gastrointestinal issues.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with iron deficiency anemia.
Not a fit: Patients with congenital blood disorders, recent blood transfusions, malabsorption syndromes, or gastrointestinal bleeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for children suffering from iron deficiency anemia.
How similar studies have performed: Other studies have shown varying results with similar iron supplementation approaches, but this specific comparison is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients having iron deficiency anemia Exclusion Criteria: 1. Patients diagnosed as congenital aplastic anemia or thalassemia (Determined from medical record). 2. Patients who were transfused in previous 4 weeks (will be determined on history) 3. Children having mal-absorption syndrome and diarrheal illnesses. (will be determined on history and medical record) 4. Gastrointestinal bleeding suggested by history of hematemesis (bloody vomit), melena (black colored stools) or bloody stools.
Where this trial is running
Peshawar, KPK
- Khyber Teaching Hospital — Peshawar, Kpk, Pakistan (Recruiting)
Study contacts
- Study coordinator: Aimal Khan, MBBS
- Email: aimalkhan871207@gmail.com
- Phone: 03481903336
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.